Astera Labs' executive leadership recently executed a notable transaction involving common stock, providing insight into internal capital movements at the technology firm. Sanjay Gajendra, who serves as President and Chief Operating Officer of Astera Labs (NASDAQ:ALAB), reported selling 280,000 shares of common stock on May 19, 2026.
These sales amounted to a total value of approximately $69.77 million. The price points for the sold shares varied between $248.495 and $251.5436. Importantly, these transactions were not executed ad hoc; rather, they followed an automated schedule established under a Rule 10b5-1 trading plan that was originally adopted on December 2, 2025.
The timing of this substantial sale is notable given the current market valuation context for Astera Labs. The stock has been trading near its 52-week high of $298.36, with shares currently observed at $297.84. Over the past year, the company's stock performance has shown a considerable rise, delivering a return of 216%. Despite this strong appreciation, an analysis from InvestingPro suggests that the company may be overvalued at its current price levels.
The sale structure involved three distinct estate planning trusts. Specifically, 200,000 shares were sold through